BioMoti Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $883K

  • Investors
  • 4

BioMoti General Information

Description

Developer of a cancer therapeutics platform designed to treat ovarian cancer. The company specializes in immunotherapeutic drug-loaded particles that target and gain entry to the tumor vasculature and cancer cells helping to increase efficacy while reducing the side effects of cancer medicine, enabling healthcare professionals to better diagnose and treat patients

Contact Information

Website
www.biomoti.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • The QMB Innovation Centre
  • 42 New Road
  • London E1 2AX
  • England, United Kingdom
+44 020
Primary Industry
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • The QMB Innovation Centre
  • 42 New Road
  • London E1 2AX
  • England, United Kingdom
+44 020

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioMoti Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 16-Oct-2017 $883K Completed Generating Revenue
6. Merger/Acquisition Cancelled Generating Revenue
5. Seed Round 30-Aug-2016 Completed Generating Revenue
4. Seed Round 01-Sep-2014 Completed Generating Revenue
3. Seed Round 08-Jan-2013 Completed Generating Revenue
2. Grant 06-Aug-2012 $234K Completed Startup
1. Grant 24-May-2011 Completed Startup
To view BioMoti’s complete valuation and funding history, request access »

BioMoti Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
To view BioMoti’s complete cap table history, request access »

BioMoti Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioMoti Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovate UK Accelerator/Incubator
Oxford Technology Management Venture Capital Minority
SEIS Fund Venture Capital Minority
Biotechnology and Biological Sciences Research Council Government
To view BioMoti’s complete investors history, request access »

Ready to get started?

Request a free trial

BioMoti FAQs

  • When was BioMoti founded?

    BioMoti was founded in 2009.

  • Where is BioMoti headquartered?

    BioMoti is headquartered in London, United Kingdom.

  • What is the size of BioMoti?

    BioMoti has 3 total employees.

  • What industry is BioMoti in?

    BioMoti’s primary industry is Drug Discovery.

  • Is BioMoti a private or public company?

    BioMoti is a Private company.

  • What is BioMoti’s current revenue?

    The current revenue for BioMoti is .

  • How much funding has BioMoti raised over time?

    BioMoti has raised $1.35M.

  • Who are BioMoti’s investors?

    Innovate UK, Oxford Technology Management, SEIS Fund, and Biotechnology and Biological Sciences Research Council have invested in BioMoti.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »